🕵️ Biomarin Pharmaceutical Inc ($BMRN)
SEC insider & ownership activity, last 12 months · CIK 1048477 · every row links its SEC filing
Over the last 12 months insiders sold $4.3M with no open-market buying against it. Davis George Eric sold $2.8M in discretionary trades (Feb–Sep). BlackRock, Inc. trimmed 10.8% → 9.1%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $4.3M (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Davis George Eric | 0 | – | 2 | $2.8M | Sep 2, 2026 |
| Guyer Charles Greg | 0 | – | 1 | $997K | Mar 11, 2026 |
| Gregory R. Friberg | 0 | – | 2 | $559K | May 7, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.1% | 13G | Jan 21, 2026 | filing ↗ | |
| Primecap Management CO/CA/ | 8.2% | 13G | Aug 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Davis George Eric | $1.2M | Sep 2, 2026 | filing ↗ |
| Gregory R. Friberg | $177K | May 7, 2026 | filing ↗ |
| Guyer Charles Greg | $997K | Mar 11, 2026 | filing ↗ |
| Gregory R. Friberg | $382K | Feb 26, 2026 | filing ↗ |
| Davis George Eric | $1.6M | Feb 26, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Sep 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Sep 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 31, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 30, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 17, 2026 | filing ↗ |
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 2, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Apr 27, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 23, 2026 | filing ↗ |
| Other events (8.01) | Mar 16, 2026 | filing ↗ |
| Earnings (2.02) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 12, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |